Key facts
- This page summarizes Robert Ticktin's Form 3 filing for PMV Pharmaceuticals, Inc. (PMVP).
- 0 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 23 Apr 2025, 18:10.
Robert Ticktin - 21 Apr 2025 Form 3 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)
- Reporting relationship
- General Counsel & COO
- Issuer ticker
- PMVP
- Reported as of
- 21 Apr 2025
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 23 Apr 2025, 18:10:03 UTC
- Next SEC filing
- 03 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Robert Ticktin
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Robert Ticktin filed Form 3 for PMV Pharmaceuticals, Inc. (PMVP) on 23 Apr 2025.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PMVP
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 106,318
- Date
- 21 Apr 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PMVP
holding
Derivative
Employee Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 21 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,449
- Exercise price
- $4.22
- Footnotes
- F2
PMVP
holding
Derivative
Employee Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 21 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 102,460
- Exercise price
- $8.53
- Footnotes
- F2
PMVP
holding
Derivative
Employee Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 21 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 168,820
- Exercise price
- $1.80
- Footnotes
- F3
PMVP
holding
Derivative
Employee Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 21 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 196,379
- Exercise price
- $1.48
- Footnotes
- F4
PMVP
holding
Derivative
Employee Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 21 Apr 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 265,000
- Exercise price
- $1.32
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Includes 79,150 shares represented by restricted stock units, or RSUs, all of which vest on June 30, 2025.
Footnote F2
Shares subject to the option are fully vested and immediately exercisable.
Footnote F3
Shares subject to the option vest in 48 equal monthly installments beginning on February 18, 2024.
Footnote F4
One-third of the shares subject to the option vest on August 13, 2025 and 1/36th vest monthly thereafter.
Footnote F5
Shares subject to the option vest in 48 equal monthly installments beginning on April 3, 2025.
SEC remarks
Exhibit 24.1 - Power of Attorney